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Introduction {#sec1}
============

The balance between proliferation and quiescence of stem cells is crucial in maintaining tissue homeostasis. Neural stem cells (NSCs) in the brain have the ability to be reactivated from a reversible quiescent state to generate new neurons. In the mammalian adult brain, the majority of adult NSCs are quiescent and are not actively dividing ([@bib16], [@bib39]). Interestingly, these quiescent NSCs can be reactivated and participate in neurogenesis upon various extrinsic stimuli ([@bib1], [@bib13], [@bib14], [@bib18], [@bib25], [@bib34], [@bib55]). Dysregulation of the balance between proliferation and quiescence of NSCs may contribute to neurodevelopmental disorders such as microcephaly ([@bib7], [@bib10]). Reactivating quiescent NSCs may also provide therapeutic strategies for the treatment of brain injuries or neurodegenerative disorders.

Recently, *Drosophila* NSCs, neuroblasts, have emerged as an excellent *in vivo* model for the study of NSC quiescence and reactivation. NSCs exit the cell cycle, shrink in size, and enter quiescence at the end of embryogenesis under the control of the spatial Hox protein, temporal identity factors, and a homeodomain differentiation factor Prospero ([@bib22], [@bib29], [@bib54]). At early larval stages, following 24 hr of quiescence, they are reactivated in response to feeding ([@bib8], [@bib23], [@bib53]). Dietary amino acids present in the food are sensed by the fat body, which functions equivalent to the mammalian liver and adipose tissue ([@bib11]). The fat body generates mitogens, stimulating blood-brain barrier glial cells to secrete insulin-like peptides (dILPs). dILPs act locally by activating the insulin receptor (InR)/phosphatidylinositol 3-kinase (PI3K)/Akt pathway in underlying NSCs and promoting their reactivation ([@bib8], [@bib9], [@bib48]). Blood-brain barrier glial cells synchronize NSC reactivation via calcium oscillations through gap junctions ([@bib49]), while cortex glial cells remodel to promote new-born neuron survival ([@bib50]). Besides InR pathway, the spindle matrix complex intrinsically promotes NSC reactivation ([@bib33]), while the Hippo pathway maintains NSC quiescence ([@bib15], [@bib40]). In mammalian brains, insulin-like growth factor-1 (IGF-1) produced by astroglial cells has a similar role in promoting NSC proliferation in response to brain injury ([@bib37], [@bib57], [@bib58]). In addition, IGF-1 receptor (IGF-1R) promotes the proliferation of mammalian NSCs ([@bib4]), and human IGF-1R mutations are associated with microcephaly ([@bib24]), suggesting that the insulin pathway is likely conserved from flies to humans in promoting NSC proliferation. However, how the insulin pathway is regulated during NSC reactivation is still poorly understood.

Here, we show that a highly conserved chaperone, Hsp83/Hsp90, is required for the activation of the InR/PI3K/Akt pathway during NSC reactivation. Hsp83 functions in a wide variety of biological processes, including cell polarity, DNA transcription, and chromatin remodeling ([@bib3], [@bib41], [@bib45], [@bib52]). Unlike Hsp70, eukaryotic Hsp83/Hsp90 does not act in nascent protein folding, rather, it binds to substrate proteins that are in a near native state at a late stage of folding ([@bib59]). We show that Hsp83 is necessary and sufficient for NSC reactivation in the presence of dietary amino acids. Its co-chaperones Cdc37 and Hsp70 mediate the association between Hsp83 and its client protein kinases and steroid hormone receptors, respectively ([@bib17], [@bib59]). We show that the activation of the InR/PI3K/Akt pathway is dependent on Hsp83 and Cdc37 function in larval brains. Hsp83 and Cdc37 physically associate with InR, but not Akt. Finally, the *hsp83* knockdown phenotype is rescued by over-activation of the InR/PI3K/Akt pathway.

Results {#sec2}
=======

Hsp83 Is Required Intrinsically for NSC Reactivation {#sec2.1}
----------------------------------------------------

To identify regulators of NSC reactivation, we used an NSC-specific driver *insc-*GAL4 to perform an unbiased RNAi screening in NSCs. Our screen identified an RNAi line (VDRC no. 108568), which knocks down *hsp83* expression, exhibiting defective NSC reactivation, with cellular extensions, a hallmark of quiescent NSCs, observed in 27.7% ± 3.0% ([Figures 1](#fig1){ref-type="fig"}A and 1E; n = 1,452, 41 brain lobes) of NSCs at 72 hr after larval hatching (ALH) at 29°C. In comparison, all control NSCs were reactivated and lost their cellular extensions at the same stage ([Figures 1](#fig1){ref-type="fig"}A and 1E; n = 1,084, 20 brain lobes). This finding suggests that these NSCs failed to be reactivated and remained in a quiescent state upon *hsp83* knockdown. Next, in order to examine if NSCs with *hsp83* knockdown are able to enter the cell cycle, we carried out 5-ethynyl-2′-deoxyuridine (EdU) incorporation experiments. All control NSCs ([Figures 1](#fig1){ref-type="fig"}B and 1F; n = 756, 20 brain lobes) incorporated EdU at 72 hr ALH at 29°C. By contrast, at the same condition, 44.7% ± 6.3% (n = 824, 24 brain lobes) of NSCs failed to incorporate EdU with *hsp83* knockdown ([Figures 1](#fig1){ref-type="fig"}B and 1F). Next, we examined the phenotype of an amorphic *hsp83*^*j5C2*^ and hypomorphic *hsp83*^*e6A*^ in mosaic analysis with a repressible cell marker (MARCM) clones ([@bib32]). While all NSCs in wild-type control clones exhibited normal round shapes without any cellular extensions (n = 58), 43.0% (n = 114) of *hsp83*^*j5C2*^ NSC clones and 36.4% (n = 266) of *hsp83*^*e6A*^ NSC clones contained NSCs with cellular extensions ([Figures 1](#fig1){ref-type="fig"}C and 1E). These observations further show that NSCs remain quiescent after loss of *hsp83*. To examine the proliferative status of the NSCs, we performed EdU pulse-chase analysis. At 96 hr ALH, all NSCs in wild-type control clones were actively dividing evident by EdU incorporation (n = 101). Unlike the wild-type control clones, 82.8% (n = 82) and 77.9% (n = 87) of NSC clones with *hsp83*^*j5C2*^ and *hsp83*^*e6A*^, respectively, failed to incorporate EdU ([Figures 1](#fig1){ref-type="fig"}D and 1F). Furthermore, the NSC quiescence phenotype of *hsp83* mutants were fully rescued by introducing a 21.8-kb bacterial artificial chromosome (BAC) CH322-129N17 containing *hsp83* (*hsp83*-BAC). A total of 39.7% (n = 126) and 36.4% (n = 107) NSCs in *hsp83*^*j5C2*^ and *hsp83*^*e6A*^ MARCM clones showed cellular extensions ([Figure S1](#mmc1){ref-type="supplementary-material"}A). However, when *hsp83*-BAC was expressed, none of NSCs in *hsp83*^*j5C2*^ (n = 117) and *hsp83*^*e6A*^ (n = 107) MARCM clones exhibited cellular extensions ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Similarly, 78.3% (n = 46) and 70.8% (n = 72) NSCs in *hsp83*^*j5C2*^ and *hsp83*^*e6A*^ MARCM clones failed to incorporate with EdU ([Figure S1](#mmc1){ref-type="supplementary-material"}A), while all NSCs *from hsp83*^*j5C2*^ with *hsp83*-BAC (n = 95) and *hsp83*^*e6A*^ with *hsp83*-BAC (n = 70) were incorporated with EdU ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Taken together, these results indicate that Hsp83 is required for NSC reactivation.Figure 1Hsp83 and Its Co-chaperone Cdc37 Are Required for NSC Reactivation(A) Larval NSCs of control (UAS-dicer2) and *hsp83* RNAi (VDRC no. 108568) induced with *insc*-Gal4 at 72 hr ALH were stained for Deadpan (Dpn) and Miranda (Mira).(B) Larval brains of control (UAS-*dicer2*) and *hsp83* RNAi (VDRC no. 108568) induced with *insc*-Gal4 at 72 hr ALH were labeled with EdU and Mira.(C) Larval NSC clones of wild-type control, *hsp83*^*e6A*^ and *hsp83*^*j5C2*^ at 96 hr ALH were stained for GFP, Dpn, and Mira. NSC lineages were marked with CD8-GFP.(D) Larval NSC clones of wild-type control, *hsp83*^*e6A*^, and *hsp83*^*j5C2*^ at 96 hr ALH were labeled with GFP, Dpn, and EdU. NSC lineages were marked with CD8-GFP.(E and F) Quantifications of cellular extensions (E) and EdU incorporation (F) for control, *hsp83* RNAi, MARCM control clone, *hsp83*^*e6A*^, and *hsp83*^*j5C2*^ MARCM clones. Data are presented as mean ± SD for RNAi knockdown.(G) Larval NSCs of control (UAS-*dicer2*) and *cdc37* RNAi (VDRC no. 47776/v47776, v110727 and BDSC no. 28756; induced with *insc*-Gal4 at 72 hr ALH were stained for Dpn and Mira).(H) Larval brains of control (UAS-*dicer2*) and *cdc37* RNAi (v47776) induced with *insc*-Gal4 at 72 hr ALH were labeled with EdU and Mira.(I and J) Larval brains of control (UAS-*dicer2*) and UAS-*hsp83*-HA under the control of *insc*-Gal4 at 6 hr ALH were labeled with EdU and Dpn. Data are presented in (J) as mean ± SD.White arrows point to NSCs and yellow arrowheads point to cellular extensions of NSCs (A, C, D, and G). Central brain is to the left of white dotted lines (B and H). Clone outline is indicated by white dotted lines (C and D). Statistical analyses were done comparing two different genotypes using a two-tailed Student\'s t test (E, F, and J). ^∗∗∗^p \< 0.001. Scale bars, 5 μm in (A), (C), (D), and (G), 30 μm in (B) and (H), and 15 μm in (I).

We carried out a time course experiment and examined larval brains at 24, 48, and 72 hr ALH. At 24 hr ALH, most control NSCs were reactivated, with only 4.9% ± 1.0% (n = 2,174, 37 brain lobes) showing cellular extensions, suggesting that they were still in quiescence ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1E). With *hsp83* knockdown under the *insc*-Gal4 driver, 15.4% ± 1.3% (n = 1,535, 28 brain lobes) of NSCs possess cellular extensions at 24 hr ALH ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1E). Loss of cellular extensions of NSCs seemed to precede cell-cycle re-entry. At 24 hr ALH, 19.5% ± 3.8% (n = 1,205, 22 brain lobes) of control NSCs failed to incorporate EdU ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1D), while 63.1% ± 5.0% (n = 1,193, 24 brain lobes) NSCs with *hsp83* knockdown were EdU-negative ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1D). This observation suggests that NSC reactivation is defective when *hsp83* is knocked down at early larval stages. At 48 hr ALH, all control NSCs showed round cell morphology without cellular extension ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1E; n = 1,625, 30 brain lobes) and nearly all of the NSCs incorporated EdU ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1D; 98.2% ± 1.4%, n = 704, 21 brain lobes). In comparison, with *hsp83* knockdown, 27.2% ± 2.9% (n = 1,254, 20 brain lobes) of NSCs still showed cellular extensions ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1E), while 48.7% ± 6.2% (n = 526, 13 brain lobes) of NSCs failed to incorporate EdU ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1D). At 72 hr ALH, all control NSCs had no cellular extensions ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1E; n = 1,221, 13 brain lobes) and incorporated EdU ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1D; n = 322, 6 brain lobes). By contrast, with *hsp83* knockdown 28.2% ± 2.1% (n = 1,003, 11 brain lobes) of NSCs showed cellular extensions ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1E) and 49.5% ± 7.4% (n = 290, 5 brain lobes) of NSCs lacked EdU incorporation ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1D). Taken together, Hsp83 is intrinsically required for NSC reactivation.

Upon *hsp83* knockdown at 72 hr ALH, the sizes of NSCs are variable, ranging from 4 to 11 μm, even when they still maintained cellular extensions, a hallmark of quiescent NSCs. At 24 hr ALH, the diameter of control NSCs was 8.7 ± 0.6 μm (n = 121), while NSC diameters were decreased to 6.8 ± 1.3 μm (n = 129) upon *hsp83* knockdown under *insc*-Gal4 (data not shown). At 72 hr ALH, the average NSC diameter upon *hsp83* RNAi knockdown is 8.1 ± 1.8 μm (n = 124), still smaller than control NSCs (10.6 ± 0.7 μm; data not shown). Similarly, at 72 hr ALH the NSC diameters of *hsp83*^*e6A*^ and *hsp83*^*j5c2*^ were 8.1 ± 1.7 μm (n = 121) and 8.2 ± 1.6 μm (n = 118), respectively. These observations suggest that, although NSC reactivation is dramatically disrupted upon knocking down *hsp83*, cell growth is incompletely blocked, resulting in enlargement of some of the quiescent NSCs. Thus, cell division and cell growth seemed to be partially uncoupled upon failure of NSC reactivation in NSCs upon *hsp83* depletion. Similar uncoupling of cell division and growth were also reported in other mutants defective in NSC reactivation including *chromator*, which appears to function downstream of the InR signaling pathway ([@bib33]).

Mushroom body (MB) neuroblasts do not enter quiescence at the end stage of embryogenesis and are capable of dividing in the absence of dietary amino acids throughout larval stages ([@bib23], [@bib48], [@bib53]). We investigated whether Hsp83 was required for general proliferation of cells, such as MB neuroblasts. At 24 hr ALH, all MB neuroblasts (Dpn^+^), which were surrounded by Dachshund-positive MB neurons, from both control (n = 224) and *hsp83* RNAi (n = 200), were incorporated with EdU ([Figure S1](#mmc1){ref-type="supplementary-material"}F). This result suggests that proliferation of MB neuroblasts is unaffected by *hsp83* RNAi knockdown.

Co-chaperone Cdc37 Is Required for NSC Reactivation {#sec2.2}
---------------------------------------------------

Functioning as a chaperone, Hsp83 has two major classes of clients, steroid hormone receptors and protein kinases, and requires co-chaperones heat shock protein 70 (Hsp70) or cell division cycle 37 (Cdc37), respectively ([@bib17]). To investigate whether steroid hormone receptors or protein kinases are the potential clients of Hsp83 during NSC reactivation, we tested whether Hsp70 or Cdc37 plays any role during NSC reactivation. There are seven isoforms of *hsp70* in *Drosophila* and we acquired 14 RNAi stocks for these isoforms ([Table S1](#mmc1){ref-type="supplementary-material"}) and knocked down these genes in NSCs using *insc*-Gal4. However, knocking down these isoforms of *hsp70* or Hsp70/Hsp90 organizing protein (*hop*), which coordinates the interaction between Hsp70 and Hsp83 by binding to both of them, did not result in any NSC reactivation defect at both 24 and 72 hr ALH ([Table S1](#mmc1){ref-type="supplementary-material"} and data not shown). By contrast, at 72 hr ALH at 29°C, in *cdc37* RNAi knockdown (VDRC no. 47776) brains, 16.8% ± 2.2% (n = 947, 11 brain lobes) of NSCs showed cellular processes ([Figure 1](#fig1){ref-type="fig"}G), and only 1.5% ± 1.4% (n = 1,135, 14 brain lobes) of NSCs were incorporated with EdU ([Figure 1](#fig1){ref-type="fig"}H). Similarly, in two other *cdc37* RNAi lines (VDRC no. 110727 and BDSC no. 28756), 16.1% ± 1.2% (n = 1,352, 18 brain lobes) and 19.7% ± 3.3% (n = 1,812, 28 brain lobes) of NSCs showed cellular extensions, respectively ([Figure 1](#fig1){ref-type="fig"}G). These observations suggest that Hsp83 likely functions together with its co-chaperone Cdc37 during NSC reactivation. *cdc37*^*e4D*^ is an amorphic allele in which almost the entire coding region of *cdc37* is deleted ([@bib12]). In wild-type NSC MARCM clones, all NSCs were devoid of cellular extensions at 96 hr ALH ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H; n = 50). By contrast, in *cdc37*^*e4D*^ MARCM clones, 28.8% (n = 198) of NSCs extend cellular processes ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H), suggesting that Cdc37 is required for NSC activation. The process phenotype of *cdc37*^*e4D*^ was fully rescued by introducing a 22.1-kb BAC CH322-35F18 containing *cdc37* (*cdc37*-BAC). A total of 25.9% (n = 85) NSCs in *cdc37*^*e4D*^ MARCM clones showed cellular extensions, while none of the NSCs (n = 71) from *cdc37*^*e4D*^ with *cdc37*-BAC showed cellular extensions ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H). Therefore, we conclude that Cdc37 is required for NSC reactivation.

Overexpression of Hsp83 Leads to Premature NSC Reactivation {#sec2.3}
-----------------------------------------------------------

To test whether Hsp83 overexpression is sufficient to trigger NSC reactivation, we overexpressed *hsp83*-hemagglutinin (HA) ([@bib27]) in NSCs using *insc*-Gal4 and examined its effect on NSC proliferation at 6 hr ALH. Hsp83-HA is functional, as it largely rescued the NSC quiescence phenotype in *hsp83*^*j5C2*^ and *hsp83*^*e6A*^ mutants (data not shown). At 6 hr ALH, most wild-type control NSCs remained in quiescence, as only 18.8% ± 4.8% of NSCs (n = 1,907, 55 brain lobes) incorporated EdU ([Figures 1](#fig1){ref-type="fig"}I and 1J). By contrast, upon *hsp83* overexpression, 41.9% ± 5.5% (n = 2,211, 62 brain lobes) of NSCs incorporated EdU ([Figures 1](#fig1){ref-type="fig"}I and 1J). This result suggests that Hsp83 overexpression leads to premature NSC reactivation. However, in the absence of dietary amino acids, Hsp83 overexpressing in NSCs was unable to promote NSC reactivation (data not shown), suggesting that Hsp83 overexpression effect is nutrition dependent. Taken together, Hsp83 is both necessary and sufficient for NSC reactivation in the presence of dietary amino acids.

pInR and Akt Levels Are Decreased upon *hsp83* Depletion {#sec2.4}
--------------------------------------------------------

Activation of the InR/PI3K/Akt pathway promotes NSC reactivation ([@bib9], [@bib48]). We investigated whether the InR/PI3K/Akt pathway is activated in NSCs with *hsp83* depleted. To this end, we first analyzed the protein levels of Akt in NSCs, a major component of the InR/PI3K/Akt pathway and a protein kinase that triggers NSC reactivation ([@bib46]). In the central brain of wild-type larvae at 72 hr ALH, Akt protein levels were comparable with its levels in the optic lobe ([Figure 2](#fig2){ref-type="fig"}A). However, upon *hsp83* knockdown in central brain NSCs by *insc*-Gal4 at 72 hr ALH, Akt protein levels in the central brain decreased significantly, while its levels in the optic lobe remained similar to control ([Figure 2](#fig2){ref-type="fig"}A). Likewise, Akt protein levels in the central brain were reduced significantly upon *cdc37* knockdown by RNAi ([Figure 2](#fig2){ref-type="fig"}A). These observations suggest that Hsp83 and Cdc37 may be required for the activation of the InR/PI3K/Akt pathway in NSCs. Next, we examined Akt protein levels in whole-brain protein extracts by western blot. *hsp83* knockdown in larval brains was efficient, as Hsp83 protein levels in the whole brain were reduced to 47.3% ± 6.8% (n = 3) in *hsp83* knockdown samples compared with controls ([Figures 2](#fig2){ref-type="fig"}B and 2C). Remarkably, Akt protein levels was only 61.7% ± 5.5% (n = 3) in *hsp83* knockdowns compared with wild-type controls ([Figures 2](#fig2){ref-type="fig"}B and 2C). Likewise, upon *cdc37* knockdown in NSCs Akt level was reduced to 67.1% ± 15.8% (n = 3), compared with wild-type control ([Figures 2](#fig2){ref-type="fig"}B and 2C). These results suggest that the InR/PI3K/Akt pathway is likely impaired upon depletion of either *hsp83* or *cdc37* in NSCs.Figure 2Hsp83 and Cdc37 Are Required for the Activation of InR Pathway(A) Larval brains of control (UAS-*dicer2*), *hsp83* RNAi (v108568), and *cdc37* RNAi (v47776) under *insc*-Gal4 at 72 hr ALH were stained for Mira, Dpn, and Akt. Yellow dotted boxes indicate the region of zoomed-in images. Central brain is to the left of white dotted lines. White arrows point to NSCs and outlines of NSCs are indicated by white dotted lines. Scale bars, 30 μm for whole brain lobe and 5 μm for single cell.(B and C) Western blot analysis of larval brain extracts of control (UAS-*dicer2*), *hsp83* knockdown (v108568), and *cdc37* knockdown (v110727) induced with *insc*-Gal4 at 72 hr ALH. Blots were probed with anti-Hsp83 antibody or anti-Akt antibody.(D and E) Western blot analysis of larval brains of control (UAS-*dicer2*), *hsp83* knockdown (v108568), *cdc37* knockdown (v110727), and *InR*^*AD*^ overexpression (O/E; induced with *insc*-Gal4) at 72 hr ALH. Blots were probed with anti-pInR antibody.(F and G) Western blot analysis of whole larvae extracts of control (UAS-*dicer2*), *hsp83*-HA overexpression induced with *insc*-Gal4 at 6 hr ALH. Blots were probed with anti-Akt antibody.(H and I) Western blot analysis of whole larvae extracts of control (UAS-*dicer2*), *hsp83*-HA overexpression induced with *insc*-Gal4 at 6 hr ALH. Blots were probed with anti-pInR antibody. Loading control, actin (B, D, F, and H).Statistical analyses were done comparing between two different genotypes using a two-tailed Student\'s t test (C, E, G, and I). ^∗^p \< 0.05, ^∗∗∗^p \< 0.001. Data are presented as mean ± SD in (C), (E), (G), and (I).

We then examined whether the protein levels of phosphorylated insulin receptor (pInR), the activated form of InR, is altered upon *hsp83* or *cdc37* depletion in larval brains. After *hsp83* knockdown in NSCs under *insc*-Gal4 at 72 hr ALH, only 16.5% ± 9.7% (n = 3) of pInR remained compared with wild-type controls ([Figures 2](#fig2){ref-type="fig"}D and 2E). Similarly, knockdown of *cdc37* in NSCs resulted in a dramatic reduction of pInR levels with 23.1% ± 0.6% (n = 3) compared with controls ([Figures 2](#fig2){ref-type="fig"}D and 2E). The mRNA levels of *InR* or *akt*, were not obviously altered with *hsp83* or *cdc37* RNAi knockdown ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B).

Taken together, we conclude that Hsp83 and Cdc37 are likely required for the activation of the InR/PI3K/Akt pathway.

Hsp83 Overexpression Results in Increase of pInR and Akt Level {#sec2.5}
--------------------------------------------------------------

Since Hsp83 overexpression triggers premature NSC reactivation, it is worthy to investigate whether Hsp83 overexpression can result in the activation of the InR/PI3K/Akt pathway. Due to insufficient amounts of protein that could be obtained due to the tiny size of larval brains at 6 hr ALH, we examined the protein levels of the whole larvae. Upon *hsp83*-HA overexpression in NSCs using *insc*-Gal4, the protein levels of Akt in the whole larvae were increased to 184.6% ± 25.9% (n = 4), compared with controls ([Figures 2](#fig2){ref-type="fig"}F and 2G). Similarly, *hsp83* overexpression in NSCs resulted in a significant increase of pInR level in whole larvae, with 383.6% ± 88.2% (n = 4) compared with controls ([Figures 2](#fig2){ref-type="fig"}H and 2I). These results suggest that overexpression of Hsp83 is sufficient to drive the activation of the InR/PI3K/Akt pathway on the fed condition.

Hsp83, Cdc37, and InR Physically Interact {#sec2.6}
-----------------------------------------

Given that Hsp83 and Cdc37 are required for the activation of the InR/PI3K/Akt pathway, we explored whether Hsp83 and Cdc37 physically interact with InR or Akt. To test the physical association between Hsp83, Cdc37, and InR, we performed a proximity ligation assay (PLA), a technique enabling high specificity and sensitivity detection of protein-protein interactions ([Figure 3](#fig3){ref-type="fig"}A) ([@bib19]). We co-expressed various proteins tagged with Myc or HA in S2 cells and quantified PLA foci that indicated interactions in cells, which co-expressed both Myc and HA-tagged proteins ([Figures 3](#fig3){ref-type="fig"}B and 3C). In S2 cells co-expressing both HA and Myc controls, the vast majority of cells (90.2%, n = 1,397) had no PLA signals and the rest of the cells displayed weak PLA fluorescence signal of less than 10 foci ([Figures 3](#fig3){ref-type="fig"}B and 3C). On average, these control cells only had 0.13 PLA foci per cell. We failed to generate full-length InR constructs, presumably due to its large size (\>6 kb). As the intracellular domain of InR including the kinase domain (InR^intra^), an active form of InR, was previously used for demonstrating protein-protein interactions for InR ([@bib2]), we decided to use InR^intra^ in PLA assays. Similarly, in the vast majority of cells co-expressing Myc-Hsp83 with control HA (n = 1,456) and HA-InR^intra^ with control Myc (n = 1,767), no PLA signal was detected and, on average, there were 0.45 and 0.38 PLA foci per cell, respectively ([Figures 3](#fig3){ref-type="fig"}B and 3C). By contrast, cells co-expressing Myc-Hsp83 and HA-InR^intra^ displayed 12.77 PLA foci per cell on average; 90.9% of cells exhibited PLA signal, with 41.8% of cells displaying moderate PLA signals (11--30 foci), 36.4% displaying weak PLA signals (≤10 foci), and 12.7% displaying strong PLA signals (\>30 foci; [Figures 3](#fig3){ref-type="fig"}B and 3C; n = 1784). In a similar PLA assay, we tested whether Hsp83 interacts with Akt. The majority of S2 cells co-expressing Myc-Akt and HA-Hsp83 had no PLA signal ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B; 76.1%, n = 1,581), suggesting that Hsp83 did not interact with Akt. These results suggest that Hsp83 physically associated with InR^intra^, but not Akt.Figure 3Hsp83, Cdc37, and InR Interact in PLA Assays(A) A schematic representation of the proximity ligation assay performed on S2 cells (refer to [Experimental Procedures](#sec4){ref-type="sec"}).(B) *In situ* PLA assay among Hsp83, Cdc37, and InR^intra^ in S2 cells. S2 cells transfected with two of the indicated plasmids (Myc, HA, Myc-Hsp83, HA-InR^intra^, Myc-Cdc37, and HA-Hsp83) were stained for HA, Myc, and DNA and screened for PLA signal. Cell outline was determined by differential interference contrast images.(C) Graphs showing the percentage of S2 cells with no PLA signal, and weak (≤10 foci), moderate (11--30 foci), and strong (\>30 foci) PLA signals for (B).Scale bars, 4 μm.

Similarly, in controls expressing Myc-Cdc37 and HA, we observed that the majority of cells (88.2%) had no PLA signal ([Figures 3](#fig3){ref-type="fig"}B and 3C; n = 1,522). However, co-expressing Myc-Cdc37 and HA-InR^intra^ resulted in 86.8% S2 cells showing PLA fluorescence; 51.3% of cells displayed weak PLA signals, 31.4% of cells showed moderate PLA signals, and 4.1% of cells showed strong PLA signals ([Figures 3](#fig3){ref-type="fig"}B and 3C; n = 1,144). In controls co-expressing HA-Hsp83 and Myc, 88.5% of S2 cells did not have any PLA signal ([Figures 3](#fig3){ref-type="fig"}B and 3C; n = 1,069). By contrast, in cells co-expressing Myc-Cdc37 and HA-Hsp83, 51.5%, 30.4%, and 4.2% of these cells displayed weak, moderate, and strong PLA signals, respectively ([Figures 3](#fig3){ref-type="fig"}B and 3C; n = 1,271).

To further validate the interactions between Hsp83, Cdc37, and InR, we employed a protein-protein interaction assay named biomolecular fluorescence complementation (BiFC), which is able to detect transient or weak interactions due to the irreversibility of the BiFC complex formation ([@bib21], [@bib47]). We generated chimeric proteins InR^intra^-HA-CYFP (InR^intra^ with C-terminal YFP tagged with HA) and Hsp83-Myc-NYFP (N-terminal YFP tagged with Myc was fused to the Hsp83). As expected, when transfecting either of these two chimeric constructs into S2 cells with their respective controls, Myc-NYFP and HA-CYFP, no YFP signal was detected in cells ([Figure S4](#mmc1){ref-type="supplementary-material"}B). By contrast, strong YFP was detected when cells were expressing both Hsp83-myc-NYFP and InR^intra^-HA-CYFP, suggesting that Hsp83 and InR^intra^ physically associate ([Figure S4](#mmc1){ref-type="supplementary-material"}B). To further test the specificity of this interaction, we generated a C-terminal truncation of Hsp83 ([Figure S4](#mmc1){ref-type="supplementary-material"}A; Hsp83C: amino acids 538--717), which presumably abolishes the dimerization of Hsp83 and its subsequent ability to form a pocket-like structure to bind to its client proteins. We tested the ability of this Hsp83 truncation to associate with InR^intra^. There was no YFP signal upon co-expression of Hsp83C-myc-NYFP with InR^intra^-HA-CYFP in S2 cells ([Figure S4](#mmc1){ref-type="supplementary-material"}B), suggesting that the association between Hsp83 and InR^intra^ was abolished with the N-terminal Hsp83 deletion. In addition, Hsp83 associated with its co-chaperone Cdc37, but not with an unrelated control WAVE in the BiFC assay ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Cdc37 also physically interacts with InR^intra^ in the BiFC assay, as S2 cells expressing both InR^intra^-HA-CYFP and Cdc37-*myc*-NYFP, but not the controls, displayed YFP signal ([Figure S4](#mmc1){ref-type="supplementary-material"}B).

Next, to examine their physical association in an *in vivo* BiFC assay, we generated transgenic flies expressing Hsp83-*myc*-NYFP, InR^intra^-HA-CYFP, Cdc37-*myc*-NYFP, and Cdc37-HA-CYFP in NSCs under the *insc*-Gal4 driver. At 72 hr ALH at 29°C, overexpressed Hsp83, Cdc37, and InR^intra^ in NSCs were observed by their respective epitope tags. As expected, there was no detectable YFP when Hsp83-*myc*-NYFP, Cdc37-*myc*-NYFP, Cdc37-HA-CYFP Cdc37, or InR^intra^-HA-CYFP were co-expressed with their corresponding control half-YFP proteins ([Figure 4](#fig4){ref-type="fig"}). By contrast, when Hsp83-*myc*-NYFP and InR^intra^-HA-CYFP were co-expressed, strong YFP was detected in NSCs ([Figure 4](#fig4){ref-type="fig"}), suggesting that Hsp83 and InR^intra^ physically associate in NSCs. Likewise, Cdc37 interacted with both InR^intra^ and Hsp83 in NSCs in the BiFC assay ([Figure 4](#fig4){ref-type="fig"}). Taken together, Hsp83, Cdc37, and InR^intra^ physically associate with one another both *in vitro* and *in vivo* in BiFC assays.Figure 4Hsp83, Cdc37, and InR Physically Associate in BiFC AssaysUAS-Hsp83-Myc-NYFP and UAS-InR^intra^-HA-CYFP were co-expressed in larval NSCs by *insc*-Gal4 at 72 hr ALH, stained for Myc, HA, and DNA and screened for YFP fluorescence. Negative controls were UAS-Hsp83-Myc-NYFP with UAS-CYFP-HA and UAS-NYFP-Myc with UAS-InR^intra^-HA-CYFP. Other transgenes used in the assay were UAS-Cdc37-Myc-NYFP and UAS-Cdc37-HA-CYFP. Scale bars, 4 μm.

Hsp83 Functions Upstream of the InR/PI3K/Akt Pathway in NSC Reactivation {#sec2.7}
------------------------------------------------------------------------

Next, we ascertained whether Hsp83 functions upstream or downstream of the InR/PI3K/Akt pathway during NSC reactivation. Over-activation of the InR/PI3K/Akt pathway by expressing various active components of this pathway overrides the requirement of dietary amino acids for NSC reactivation ([@bib9], [@bib48]). We explored whether depletion of *hsp83* was able to abrogate this effect of InR/PI3K/Akt pathway over-activation. Overexpression of an active form of InR (i.e., InR^AD^, BDSC no. 8440) under the *insc*-Gal4 drove NSC reactivation in the absence of dietary amino acid (sucrose-only food), as there were 32.8 ± 13.9 (n = 22) EdU^+^ cells per brain hemisphere at 72 hr ALH ([Figures 5](#fig5){ref-type="fig"}A and 5B). Similarly, at the same growth condition, when *hsp83* was depleted in InR^AD^-overexpressing brains, there were 32.5 ± 14.6 (n = 25) EdU^+^ cells per brain hemisphere ([Figures 5](#fig5){ref-type="fig"}A and 5B). Likewise, at 24 hr ALH in sucrose-only food, in InR^AD^-overexpressing brains with *hsp83* RNAi knockdown, there were 17.1 ± 6.6 (n = 20) EdU^+^ cells per hemisphere ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B), similar to InR^AD^ overexpression alone ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B; 21.3 ± 5.0 EdU^+^ cells per hemisphere, n = 32). These observations suggest that over-activation of InR was epistatic to *hsp83* depletion in NSCs. Therefore, Hsp83 likely functions upstream of InR during NSC reactivation.Figure 5Hsp83 Functions Upstream of the InR/PI3K/Akt Pathway during NSC Reactivation(A and B) Larval brains of *hsp83* knockdown (v108568) with UAS-CD8-GFP, *InR*^*AD*^ overexpression (BDSC no. 8440) with UAS-CD8-GFP, and *InR*^*AD*^ overexpression with *hsp83* knockdown (v108568) under *insc*-Gal4 at 72 hr ALH in sucrose-only food were labeled with EdU and DNA. *hsp83* knockdown, 4.3 ± 0.5 (n = 16) EdU^+^ cells per brain hemisphere at 72 hr ALH.(C and D) Larval brains of *hsp83* knockdown (v108568) with UAS-CD8-GFP, *Rheb*^*wt*^ overexpression (BDSC no. 9689) with UAS-CD8-GFP, and *Rheb*^*wt*^ overexpression with *hsp83* knockdown (v108568) under *insc*-Gal4 at 48 hr ALH in sucrose-only food were labeled with EdU and DNA. *hsp83* knockdown, 4.0 ± 0.4 (n = 20) EdU^+^ cells per brain hemisphere at 48 hr ALH.(E and F) Larval brains of control (UAS-*dicer2*), *hsp83* knockdown (v108568) with UAS-CD8-GFP, *InR*^*AD*^ overexpression (BDSC no. 8440) with UAS-CD8-GFP, *InR*^*AD*^ overexpression with *hsp83* knockdown (VDRC no. 108568), *Rheb*^*wt*^ overexpression (BDSC no. 9689) with UAS-CD8-GFP, and *Rheb*^*wt*^ overexpression with *hsp83* knockdown (v108568) induced with *insc*-Gal4 at 48 hr ALH in normal food were labeled with EdU and Dpn. Yellow dotted boxes indicate the region of zoomed-in images.Data are presented in (B), (D), and (F) as mean ± SD. Statistical analyses were done by pairwise comparison between two different genotypes using a two-tailed Student\'s t test (B, D, and F). ns, not significant; ^∗∗∗^p \< 0.001. Scale bars, 15 μm in (A) and (C), 30 μm for whole brain lobe, and 5 μm for single cell in (E).(G) A working model.

Rheb is a GTPase and a downstream effector of the InR/PI3K/Akt pathway in NSC reactivation ([@bib46]). In sucrose-only food at 24 hr ALH, there were 15.2 ± 2.8 (n = 42) EdU^+^ cells per brain hemisphere upon Rheb^wt^ overexpression (wild-type form, BDSC no. 9689) under the *insc*-Gal4 ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5D). Under the same conditions, 13.8 ± 3.4 EdU^+^ cells (n = 48) were observed in larval brains overexpressing Rheb^wt^ with *hsp83* RNAi knockdown ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5D). Likewise, at 48 hr ALH on sucrose-only food, the number of EdU^+^ cells were similar in Rheb^wt^-overexpressing brains with ([Figures 5](#fig5){ref-type="fig"}B and 5D; 21.6 ± 4.0, n = 26) and without *hsp83* depletion ([Figures 5](#fig5){ref-type="fig"}B and 5D; 18.5 ± 4.2, n = 27).

Under fed conditions, InR^AD^ or Rheb^wt^ overexpression also significantly rescued NSC quiescence phenotype caused by *hsp83* knockdown. At 48 hr ALH, vast majority of control NSCs were reactivated, except for 1.62% ± 0.8% NSCs without EdU incorporation ([Figures 5](#fig5){ref-type="fig"}E and 5F; n = 2410, 24 brain lobes). Similarly, almost all NSCs with InR^AD^ or Rheb^wt^ overexpression were reactivated as well, with none ([Figures 5](#fig5){ref-type="fig"}E and 5F; n = 2,412, 24 brain lobes) or 0.3% ± 0.4% ([Figures 5](#fig5){ref-type="fig"}E and 5F; n = 1,757, 18 brain lobes) NSCs without EdU incorporation. Upon *hsp83* RNAi knockdown in NSCs, 48.9% ± 8.2% ([Figures 5](#fig5){ref-type="fig"}E and 5F; n = 1,357, 17 brain lobes) lacked EdU incorporation. By contrast, at the same time point, in NSCs overexpressing InR^AD^ or Rheb^wt^ concomitant with *hsp83* RNAi knockdown, the percentages of EdU^−^ NSCs were decreased significantly to 11.7% ± 1.5% ([Figures 5](#fig5){ref-type="fig"}E and 5F; n = 2,392, 26 brain lobes) and 10.4% ± 2.3% ([Figures 5](#fig5){ref-type="fig"}E and 5F; n = 1,827, 22 brain lobes).

Taken together, overexpression of InR^AD^ or Rheb^wt^ significantly rescued NSC reactivation defects observed upon *hsp83* RNAi knockdown.

Amino Acids Deprivation Causes Significant Downregulation of *hsp83* mRNA and Inactivation of InR/PI3K/Akt Pathway {#sec2.8}
------------------------------------------------------------------------------------------------------------------

To explore whether the expression of *InR*, *hsp83*, and *cdc37* are nutrition dependent, we assessed the RNA level of *InR*, *hsp83*, and *cdc37* in larvae upon amino acid deprivation. At 24 hr ALH in sucrose-only food, the mRNA levels of *hsp83* were dramatically reduced to 13.4% ± 3.2% and 10.4% ± 3.1% measured by two different primer pairs (n = 4 each), compared with control larvae raised under fed conditions at the same time point ([Figure S5](#mmc1){ref-type="supplementary-material"}E). RNA level of *cdc37* remains unchanged on the starvation condition ([Figure S5](#mmc1){ref-type="supplementary-material"}E). This suggests that the expression of *hsp83*, but not *cdc37*, is dependent on the presence of dietary amino acids. Surprisingly, the mRNA level of *InR* and *4E-binding protein* (*4E-BP*) on sucrose-only food was increased significantly to at least 5-fold ([Figure S5](#mmc1){ref-type="supplementary-material"}E; n = 4). This result is in line with the previous finding that increased transcription of *InR* and *4E-BP* was correlated with inactivation of InR pathway and growth inhibition when nutrients are limited due to a feedback control mechanism for the InR pathway ([@bib42]). Since the upregulation of mRNA levels of *InR* in the entire larvae upon amino acid deprivation was not observed in larval brains upon knocking down of *hsp83* alone, this effect likely involves additional factors that are altered by depletion of dietary amino acids or due to different experimental conditions. Therefore, amino acid deprivation causes dramatic downregulation of *hsp83* and inactivation of InR/PI3K/Akt pathway.

Discussion {#sec3}
==========

How the InR/PI3K/Akt pathway is regulated during NSC reactivation is poorly understood. Here we show that molecular chaperone Hsp83/Hsp90, together with its co-chaperone Cdc37, play a role in the reactivation of *Drosophila* NSCs. Mechanistically, Hsp83 and Cdc37 physically associate with InR and are important for the activation of the InR/PI3K/Akt pathway in NSCs. Therefore, we demonstrate that Hsp83 serves as an intrinsic factor within NSCs that is necessary for the activation of the InR/PI3K/Akt pathway and, in turn, reactivation of NSCs. Our evidence suggests that Hsp83 and Cdc37 regulate the protein folding and activation of InR in the nervous system.

The role of Hsp83 in NSC reactivation at early larval stages is distinct from its known role in centrosomes or NSC polarity. *Drosophila* Hsp83 is a core centrosomal component required for proper mitotic spindle formation and chromosome segregation ([@bib30]). In *Drosophila* larval CNS, Hsp83 and co-chaperone Sgt1 are required for the stabilization of Polo and centrosome organization in NSCs ([@bib38]). Hsp83 and Sgt1 are also required for the establishment of NSC polarity via the LKB1/AMPK pathway in third-instar larvae ([@bib3]). However, *sgt1* RNAi (BDSC no. 34605) in NSCs did not display any phenotypes during NSC reactivation (data not shown), suggesting that Hsp83 interacts with different co-chaperones to control NSC reactivation and cortical polarity at different developmental stages. Consistent with this notion, we found that Cdc37, but not other co-chaperones of Hsp83, is required for NSC reactivation. We found that the proliferation of MB NSCs were unaffected by *hsp83* knockdown, Therefore, Hsp83 promotes NSC reactivation rather than general cell proliferation. Consistent with our observations, there is no significant difference in proliferation between *hsp83* mutant and wild-type eye imaginal discs in the proliferating zone ([@bib5]). Interestingly, in pupal eyes that undergo terminal differentiation, Hsp83 is required for cell-cycle exit by activating the anaphase-promoting complex/cyclosome ([@bib5]). We found cytokinesis defects in *cdc37*-depleted NSCs, but not in NSCs depleted of Hsp83 (data not shown). This observation is consistent with a known role of Cdc37 in cell division and cytokinesis in *Drosophila* ([@bib31]).

Hsp90 plays a key role in signal transduction and appears to bind to its substrates in a near native state poised for activation by binding of ligand or other factors ([@bib59]). Since Hsp83 overexpression is sufficient to drive the activation of InR/PI3K/Akt pathway and trigger premature NSC reactivation, Hsp83 likely plays an active role in promoting NSC reactivation by binding to InR at a late stage of folding poised for activation by dILP binding. Furthermore, in the absence of dietary amino acids, the expression of *hsp83* is downregulated, likely partially contributing to the inactivation of the InR pathway ([Figure S5](#mmc1){ref-type="supplementary-material"}E). We propose that InR is a target of Hsp83 and Cdc37 during NSC reactivation. The physical association among Hsp83, Cdc37, and InR was strongly supported by PLA assays, and both *in vitro* and *in vivo* BiFC. Although tandem affinity purification-mass spectrometry in *Drosophila* S2 cells implied an interaction between Hsp83 and InR ([@bib20]), we failed to detect a consistent interaction between Hsp83 and InR^intra^ in S2 cells in co-immunoprecipitation experiments, probably due to the transient nature of this interaction. In addition, our genetic interaction experiments indicate that Hsp83 activates the InR/PI3K/Akt pathway to promote NSC reactivation. Taken together, InR is likely a client of Hsp83 in *Drosophila* NSCs. Consistent with our findings, in human fibroblasts, Hsp90 co-immunoprecipitated with intracellular InR β subunit ([@bib51]). Furthermore, Hsp90 facilitates the maturation of the InR precursor in the ER and, in turn, is required for cell surface expression of InR in both bovine adrenal medullary chromaffin cells and human kidney HEK293 cells ([@bib43], [@bib44]). Therefore, the interaction between the Hsp90 chaperone family and InR may be conserved from *Drosophila* to humans. In mammals, the expression level of Hsp90 in the brain is the highest among all tissues ([@bib6]). Although mammalian Hsp90 proteins are heavily implicated in neurodegenerative diseases ([@bib28], [@bib35]), their function in brain development is not well understood. Hsp90/Cdc37 stabilize the intracellular domain of Ryk, a Wnt receptor required for neurogenesis ([@bib36]). Furthermore, Hsp90 stabilizes hypoxia-inducible factor-1, which promotes NSC proliferation under hypoxia ([@bib56]). It remains to be determined whether the interaction between mammalian Hsp90 and InR is conserved during mammalian NSC development.

Experimental Procedures {#sec4}
=======================

Fly Stocks and Genetics {#sec4.1}
-----------------------

The fly strains used in this study were: UAS-CYFP-HA, UAS-NYFP-Myc, UAS-Hsp83-Myc-NYFP, UAS-InR^intra^-HA-CYFP, UAS-Cdc37-Myc-NYFP, UAS-Cdc37-HA-CYFP, UAS-Hsp83-HA (T. Wang), *hsp83-*BAC, and *cdc37-*BAC. The following stocks were obtained from Bloomington Drosophila Stock Center (BDSC): RNAi for Hop and various isoforms of Hsp70 listed in [Table S1](#mmc1){ref-type="supplementary-material"}, *cdc37* RNAi (BDSC no. 28756), *cdc37*^*e4D*^ (BDSC no. 5693), UAS-InR.A1325D (InR^AD^, BDSC no. 8440), UAS-Rheb^wt^ (BDSC no. 9689), and *hsp83*^*e6A*^ (BDSC no. 36576). RNAi lines including *hsp83* RNAi (VDRC no. 108568) and *cdc37* RNAi (VDRC nos. 47776 and 110727) were obtained from Vienna Drosophila Resource Center (VDRC). *Hsp83*^*j5C2*^ (DGRC no. 111379) was obtained from Kyoto Drosophila Genetic Resource Center. All experiments were carried out at 25°C, except for RNAi knockdown or overexpression at 29°C.

Immunochemistry {#sec4.2}
---------------

Larval brains were dissected in PBS and fixed for 22 min in 0.3% PBS-Triton (PBT) with 4% electron microscopy (EM)-grade formaldehyde (methanol free). Fixed brains were processed for immunostaining as described previously ([@bib26]). Further details and primary antibodies used can be found in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

MARCM Analysis {#sec4.3}
--------------

To generate MARCM clones, late first-instar larvae were heat shocked for 2 hr at 37°C, and heat shocked for a second time 10--16 hr later after recovering at 25°C. Larvae were dissected at the third instar-larval stage and for the tissue processed by immunochemistry.

EdU Pulse-Chase Analysis {#sec4.4}
------------------------

Larvae were fed with standard food supplemented with 0.2 mM EdU from *Click*-iT EdU Alexa Fluor 555 Imaging Kit (Invitrogen) for 4 hr prior to dissection. The dissected larval brains were then fixed with 4% EM-grade formaldehyde (in 0.3% PBT) for 22 min. The brains were then processed for as described previously ([@bib33]).
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